RKO-E6 Cells
CAD$759.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | RKO-E6 cells are a human colorectal carcinoma cell line derived from the RKO cell line through additional mutagenesis. These cells are commonly used in cancer research, particularly focusing on colorectal cancer. The E6 variant of the RKO line offers a distinct profile that is useful for examining the effects of specific genetic manipulations and studying the molecular mechanisms of tumorigenesis and metastasis in colorectal cancer. RKO-E6 cells are characterized by several unique features, including alterations in genes related to cell cycle regulation, apoptosis, and DNA repair pathways. These modifications enhance the cell line's utility for investigating the biological effects of gene silencing or overexpression within a colorectal cancer context. For example, RKO-E6 cells have been employed to study the impact of tumor suppressor genes and oncogenes on cancer cell behavior, including proliferation, invasion, and resistance to chemotherapeutic agents. Furthermore, RKO-E6 cells are useful in studies aimed at understanding the cellular responses to environmental stressors, such as oxidative stress and DNA-damaging agents, which are relevant to the pathogenesis and progression of colorectal cancer. Their robust growth characteristics and genetic stability make them a valuable model for high-throughput screening assays to evaluate the efficacy of new anticancer compounds. In summary, RKO-E6 cells provide a critical model for advancing our knowledge of colorectal cancer biology and for developing and testing novel therapeutic strategies targeted at this prevalent and often deadly disease. |
|---|---|
| Organism | Human |
| Tissue | Colon |
| Disease | Colon carcinoma |
| Synonyms | RKOE6 |
Characteristics
| Morphology | Epithelial |
|---|---|
| Growth properties | Adherent |
Regulatory Data
| Citation | RKO-E6 (Cytion catalog number 305135) |
|---|---|
| Biosafety level | 2 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_3787 |
| GMO Status | GMO-S1: This human colorectal carcinoma cell line (RKO-E6) contains a plasmid encoding HPV-16 E6 under CMV promoter control, possibly including CMV and HPV-6 sequences, enabling E6-dependent transformation studies. The construct is stably integrated. This classification applies only within Germany and may differ elsewhere. |
Biomolecular Data
Handling
| Culture Medium | EMEM (MEM Eagle), w: 2 mM L-Glutamine, w: 2.2 g/L NaHCO3, w: EBSS (Cytion article number 820100a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS and 1% NEAA |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305135-260124 | Certificate of Analysis | 23. May. 2025 | 305135 |